1-20 of 430
Health Services and Outcomes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

Open Access
John A. Ligon, Lingyun Ji, Alice Dang, Xinxin Xu, Susan R. Rheingold, Deepa Bhojwani, Meenakshi Devidas, John A. Kairalla, Mary Shago, Nyla A. Heerema, Andrew J. Carroll, Michael Borowitz, Brent L. Wood, Naomi J. Winick, William L. Carroll, Stephen P. Hunger, Elizabeth A. Raetz, Mignon L. Loh, Sumit Gupta, Lena E. Winestone
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5738–5751.
https://doi.org/10.1182/bloodadvances.2025016670
Published: 2025
Includes: Supplemental data
Journal Articles

Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis

Open Access
Zachary D. Epstein-Peterson, Anath C. Lionel, Ashlee Joseph, Esther Drill, Suheil Albert Atallah-Yunes, Taylor R. Brooks, Elise A. Chong, Emeline R. Chong, Jamie Dela Cruz, Matthew J. Frank, Andrew Ip, Madiha Iqbal, Caron A. Jacobson, Manali K. Kamdar, Reem Karmali, Ofrat Beyar-Katz, Kami J. Maddocks, Matthew J. Matasar, Daniel McLoughlin, Reid W. Merryman, Javier L. Munoz, Rohini Navalekar, Joanna Rhodes, Peter A. Riedell, Christine E. Ryan, Gilles Salles, Craig S. Sauter, Yazeed Sawalha, Samanvaya Sharma, Roni Shouval, Navika Shukla, Dylan Therwhanger, Herman van Besien, Ben Varon, Yucai Wang, Samuel Yamshon, Andrew D. Zelenetz, Maria Lia Palomba, Preetesh Jain, Anita Kumar
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5654–5662.
https://doi.org/10.1182/bloodadvances.2025016315
Published: 2025
Includes: Supplemental data
Journal Articles

Beyond the CAR-T horizon in mantle cell lymphoma

Open Access
Thomas E. Lew, John F. Seymour
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5651–5653.
https://doi.org/10.1182/bloodadvances.2025017583
Published: 2025
Journal Articles

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Open Access
Xu Zhang, Michael R. DeBaun, Kristin Wuichet, Rima Zahr, Zalaya Ivy, Mitchell J. Weiss, Alex G. Bick, Victor R. Gordeuk, Santosh L. Saraf
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5610–5615.
https://doi.org/10.1182/bloodadvances.2025017204
Published: 2025
Includes: Supplemental data
Journal Articles

Intranasal Fentanyl and Impact of an Emergency Department Pain Protocol for Sickle Cell Disease on Hospitalization Rates

Open Access
Olufuke Y Martin, Sean M Thompson, Matthew Hays, Seethal A Jacob
Journal: Blood Advances
Blood Adv bloodadvances.2025016309.
https://doi.org/10.1182/bloodadvances.2025016309
Published: 2025
Includes: Supplemental data
Journal Articles

Immunoglobulin use, survival, and infection outcomes in patients with chronic lymphocytic leukemia

Open Access
Sara Carrillo de Albornoz, Xin Zhang, Rainier Arnolda, Aleece MacPhail, Adam Irving, Alisa M. Higgins, Erica M. Wood, Zoe K. McQuilten, Dennis Petrie
Journal: Blood Advances
Blood Adv (2025) 9 (20): 5367–5377.
https://doi.org/10.1182/bloodadvances.2025015867
Published: 2025
Includes: Supplemental data
Journal Articles

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers

Open Access
Lewis T. Go, Lucas T. Go, Madugodaralalage D. S. K. Gunaratne, Alexandra P. Wolanskyj-Spinner, Aneel A. Ashrani, Michelle A. Elliott, Richard L. Godby, Christopher C. Hook, Leslie J. Padrnos, Rajiv K. Pruthi, Candido E. Rivera, Rachelle L. Rouse, Surbhi Shah, Marwan E. Shaikh, Mustaqeem A. Siddiqui, Meera Sridharan, Ewa M. Wysokinska, Ronald S. Go, Jithma P. Abeykoon
Journal: Blood Advances
Blood Adv (2025) 9 (20): 5343–5346.
https://doi.org/10.1182/bloodadvances.2025016644
Published: 2025
Journal Articles

Updating clinical guidelines with limited evidence: case study of ASH/ISTH pediatric VTE treatment guidelines

Open Access
Ali Choaib, Aseel AlKhader, Muayad Azzam, Hassan Kawtharany, Marisol Betensky, Leslie Raffini, Rachel Bercovitz, Sara K. Vesely, Paul Monagle, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2025) 9 (20): 5347–5349.
https://doi.org/10.1182/bloodadvances.2025017398
Published: 2025
Journal Articles

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Open Access
Abdulrahman Alhajahjeh, Kishan K. Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez, Stuart Seropian, Lohith Gowda, Scott F. Huntington, Maximilian Stahl, Amer M. Zeidan, George Goshua, Jan Philipp Bewersdorf
Journal: Blood Advances
Blood Adv (2025) 9 (20): 5234–5246.
https://doi.org/10.1182/bloodadvances.2025016532
Published: 2025
Includes: Supplemental data
Journal Articles

Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: the impact of donor type

Open Access
Yosra M. Aljawai, Jeremy Ramdial, Portia Smallbone, George Chen, Partow Kebriaei, Oren Pasvolsky, Uday Popat, Betul Oran, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rohtesh S. Mehta
Journal: Blood Advances
Blood Adv (2025) 9 (20): 5201–5206.
https://doi.org/10.1182/bloodadvances.2025016592
Published: 2025
Includes: Supplemental data
Journal Articles

Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures

Open Access
Michelle H Lee, Yating Wang, Angel M. Cronin, Angela C Tramontano, Lachelle D. Weeks, Gabriela S Hobbs
Journal: Blood Advances
Blood Adv bloodadvances.2025017168.
https://doi.org/10.1182/bloodadvances.2025017168
Published: 2025
Includes: Supplemental data
Journal Articles

Moving the needle on chronic GVHD of the lung

Open Access
Clinical Trials & Observations
Julie R. Boiko, Kenneth R. Cooke
Journal: Blood Advances
Blood Adv (2025) 9 (19): 5038–5039.
https://doi.org/10.1182/bloodadvances.2025017297
Published: 2025
Journal Articles

Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease

Open Access
Clinical Trials & Observations
Husham Sharifi, Carson Tyler Moss, Zayan Musa, Alexander Bell, Christian O’Donnell, Carlos Hernandez Borges, Efthymia Iliana Matthaiou, Laura Johnston, Craig J. Galban, Ajay Sheshadri, Gregory Yanik, Guang-Shing Cheng, Joe L. Hsu
Journal: Blood Advances
Blood Adv (2025) 9 (19): 5024–5037.
https://doi.org/10.1182/bloodadvances.2025016122
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes and survival prediction in adults with sickle cell disease treated with extracorporeal membrane oxygenation

Open Access
Alison Grazioli, Michael Plazak, Kate Willsey, Joseph Rabin, Raymond P. Rector, Leonid Belyayev, Allison S. Lankford, Thomas M. Scalea, Aakash Shah, Bradley S. Taylor, Mark T. Gladwin
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4881–4890.
https://doi.org/10.1182/bloodadvances.2025016368
Published: 2025
Includes: Supplemental data
Journal Articles

A standardized metric to define a successful transition from pediatric to adult care in sickle cell disease

Open Access
Galia Pollock, Susanna Curtis
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4622–4623.
https://doi.org/10.1182/bloodadvances.2025017088
Published: 2025
Journal Articles

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis

Open Access
Andrea P. Chung, Jason T. Shafrin, Sachin Vadgama, Kristen Hurley, Miguel-Angel Perales, Leonard C. Alsfeld, Sanjana Muthukrishnan, Anik R. Patel, Gunjan L. Shah, Richard T. Maziarz
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4727–4735.
https://doi.org/10.1182/bloodadvances.2024015634
Published: 2025
Includes: Supplemental data
Journal Articles

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas

Open Access
Clinical Trials & Observations
Pierre Stephan, Roberta Di Blasi, Louise Roulin, Jean Galtier, Julien Calvani, Véronique Meignin, Marie Donzel, Alexandra Traverse-Glehen, Elsa Poullot, Marie Parrens, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Roch Houot, Francois-Xavier Gros, François Lemonnier, Emmanuel Bachy, Catherine Thieblemont, Pierre Sesques
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4693–4704.
https://doi.org/10.1182/bloodadvances.2025015834
Published: 2025
Includes: Supplemental data
Journal Articles

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels

Open Access
Rahul Banerjee, Meera Mohan, Kai Rejeski, Benjamin R. Puliafito, Diana D. Cirstea, Gurbakhash Kaur, Shonali Midha, Georgia J. McCaughan, Nikhil M. Kumar, Nikita Mehra, Bhausaheb Bagal, Noopur S. Raje
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4720–4726.
https://doi.org/10.1182/bloodadvances.2025016490
Published: 2025
Journal Articles

Estimation of benefit to bispecific antibodies in US patients with lymphoma and multiple myeloma

Open Access
Fausto Alfredo Rios-Olais, Talal Hilal
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4673–4675.
https://doi.org/10.1182/bloodadvances.2025016176
Published: 2025
Includes: Supplemental data
Journal Articles

National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease

Open Access
Stephanie Howe Guarino, Akshat Jain, Mohan Madisetti, Kenneth Rivlin, Payal C. Desai, Julie Kanter, Sophie Lanzkron, Deepa Manwani
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4585–4591.
https://doi.org/10.1182/bloodadvances.2025015909
Published: 2025
Includes: Supplemental data